51 related articles for article (PubMed ID: 25943864)
1. Conservative Treatment Seems the Best Choice in Adenocarcinoma In Situ of the Cervix Uteri.
Baalbergen A; Molijn AC; Quint WG; Smedts F; Helmerhorst TJ
J Low Genit Tract Dis; 2015 Jul; 19(3):239-43. PubMed ID: 25943864
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma In Situ of the Uterine Cervix (AIS) Treated by Loop Electrosurgical Excision Procedure Strategy: An Observational Study.
Soegaard-Andersen E; Frandsen AP; Sandahl P
J Low Genit Tract Dis; 2024 Apr; 28(2):149-152. PubMed ID: 38251975
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Follow-Up Outcomes in Women with In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix Undergoing Conservative Treatment-Cervical Adenocarcinoma Study Group Italian Society of Colposcopy and Cervico-Vaginal Pathology.
Giannella L; Delli Carpini G; Di Giuseppe J; Grelloni C; Bogani G; Dri M; Sopracordevole F; Clemente N; Giorda G; De Vincenzo R; Evangelista MT; Gardella B; Dominoni M; Monti E; Alessi C; Alessandrini L; Guerriero A; Pagan A; Caretto M; Ghelardi A; Amadori A; Origoni M; Barbero M; Raspagliesi F; Simoncini T; Vercellini P; Spinillo A; Scambia G; Ciavattini A
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539572
[TBL] [Abstract][Full Text] [Related]
4. Carcinogenic ability quantification of human papilloma virus subtypes in eastern China.
Zhu X; Liu H; Wu H; Liu W; Yin L; Sun X
J Med Virol; 2015 Dec; 87(12):2106-13. PubMed ID: 26112600
[TBL] [Abstract][Full Text] [Related]
5. Laser micro-dissection and qPCR for identifying specific HPV types responsible for malignancy in penile lesions.
Lebelo RL; Thys S; Benoy I; Depuydt CE; Bogers JP; Bida MN; Mphahlele MJ
J Med Virol; 2015 Oct; 87(10):1761-8. PubMed ID: 26112393
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.
Castilho JL; Levi JE; Luz PM; Cambou MC; Vanni T; de Andrade A; Derrico M; Veloso VG; Grinsztejn B; Friedman RK
BMC Cancer; 2015 Jun; 15():478. PubMed ID: 26100400
[TBL] [Abstract][Full Text] [Related]
7. Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.
Hariri S; Johnson ML; Bennett NM; Bauer HM; Park IU; Schafer S; Niccolai LM; Unger ER; Markowitz LE;
Cancer; 2015 Aug; 121(16):2775-81. PubMed ID: 26098295
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
[TBL] [Abstract][Full Text] [Related]
9. HPV Genotyping in the Prevention of Cervical Cancer-How and When Can It Be a Useful Marker?
Del Mistro A
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1302-3. PubMed ID: 26088704
[No Abstract] [Full Text] [Related]
10. Development of a Multiplex PCR Test with Automated Genotyping Targeting E7 for Detection of Six High-Risk Human Papillomaviruses.
Paes EF; de Assis AM; Teixeira CS; Aoki FH; Teixeira JC
PLoS One; 2015; 10(6):e0130226. PubMed ID: 26087285
[TBL] [Abstract][Full Text] [Related]
11. Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.
Persson M; Elfström KM; Olsson SE; Dillner J; Andersson S
PLoS One; 2015; 10(6):e0127444. PubMed ID: 26083247
[TBL] [Abstract][Full Text] [Related]
12. Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.
Poljak M
Clin Microbiol Infect; 2015 Sep; 21(9):806-7. PubMed ID: 26068650
[No Abstract] [Full Text] [Related]
13. Expressions of E2 and E7-HPV16 proteins in pre-malignant and malignant lesions of the uterine cervix.
Ramirez N; Guerra F; Camporeale G; Quintana S; Diaz LB; Cuneo N; Villacorta Hidalgo J; Tatti SA; Alonso LG; Borkosky SS; Prat Gay G; Palaoro L
Biotech Histochem; 2015; 90(8):573-80. PubMed ID: 26052817
[TBL] [Abstract][Full Text] [Related]
14. HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.
Frimer M; Sun C; McAndrew T; Smith B; Harari A; Chen Z; Mirabello L; Wentzensen N; Goldberg GL; Rodriguez AC; Schiffman M; Burk RD
Gynecol Oncol; 2015 Jul; 138(1):94-100. PubMed ID: 26001326
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study.
Zhang C; Liu F; Deng Q; He Z; Xi L; Liu Y; Pan Y; Ning T; Guo C; Xu R; Zhang L; Cai H; Ke Y
Sex Transm Infect; 2015 Nov; 91(7):506-9. PubMed ID: 25999521
[TBL] [Abstract][Full Text] [Related]
16. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
17. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.
Jiang Y; Chen C; Li L
PLoS One; 2017; 12(1):e0170587. PubMed ID: 28125627
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.
Teoh D; Musa F; Salani R; Huh W; Jimenez E
Obstet Gynecol; 2020 Apr; 135(4):869-878. PubMed ID: 32168211
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
